Read on Twitter
1> $TDOC Per call with Cramer, Teladoc CEO mentioned only 10% of visits are covid related. Since 18% of revenue is visit related, that makes direct covid impact to revenue only 1.8%. There maybe some indirect impact as well, but that is more difficult to quantify.
2> However, given the vaccine itself will take some time to get distributed to majority of population over major part of next year and vaccinated people can still be carriers, I don't see a significant indirect revenue impact ( in terms of lower engagement in target population).
3> Given LVGO growth engine will add to the current 30-40% organic projected growth by Teladoc next year, I still see this company growing at 50%+ or more next year. Zero interest regime should continue to reward growth. $TDOC will also have now higher margins now from LVGO.
4> Based on all above, even with current low valuation, I can put a price of $300+ to $TDOC by end of next year which is my conservative estimate.
